ONESOURCE SPECIALTY PHARMA
Back to Income Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-18 Cr | ₹-391 Cr | ₹-800 Cr | ₹-231 Cr | ₹-231 Cr |
What is the latest Consolidated Net Profit of ONESOURCE SPECIALTY PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-18 Cr |
| Mar2025 | ₹-391 Cr |
| Mar2024 | ₹-800 Cr |
| Mar2023 | ₹-231 Cr |
| Mar2022 | ₹-231 Cr |
How is Consolidated Net Profit of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-18 Cr | Negative | |
| Mar2025 | ₹-391 Cr | Negative | |
| Mar2024 | ₹-800 Cr | Negative | |
| Mar2023 | ₹-231 Cr | Negative | |
| Mar2022 | ₹-231 Cr | - | |
Compare Consolidated Net Profit of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,165.0 Cr | -0.6% | 18.7% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -0.6% |
18.7% |
-8.7% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses